03:49 AM EDT, 06/27/2024 (MT Newswires) -- Recursion Pharmaceuticals ( RXRX ) said late Wednesday it priced a public offering of 30.8 million shares of its class A common stock at $6.50 per share for expected gross proceeds of about $200 million.

The company granted the underwriters a 30-day option to purchase up to an additional 4.6 million shares.

The offering is expected to close Friday.

Price: 8.06, Change: -0.70, Percent Change: -7.99